National Weight-Loss Study Open At Moores UCSD Cancer Center

 

April 10, 2007  |  

Nutrition experts at the Moores UCSD Cancer Center and Scripps Clinic in Del Mar are seeking obese men and women to participate in a research study for weight loss employing an investigational combination drug therapy and behavioral modification. Study participants will receive at no cost medical evaluations, individualized diet and exercise programs, weekly nutritional and lifestyle group sessions, and the investigational study drugs or placebo.

The UCSD and Scripps collaboration represents one of nine study sites in the U.S. The study drugs have been shown to be safe and effective in preliminary clinical trials and are FDA approved for other conditions but not yet for weight loss.

To be eligible for this study, an individual must be obese, a non-smoker for at least six months, between 18 and 65 years of age, non-diabetic and in overall good health.

For further information, call the clinical research coordinator at UCSD Moores Cancer Center, 858-822-2779.

# # #

Media Contact:  Nancy Stringer,  619-543-6163, nstringer@ucsd.edu




Media Contact

Share This Article


Related News

9/22/2017
More than 100 physicians from UC San Diego Health were named “Top Docs” in the annual San Diego Magazine “Physicians of Exceptional Excellence” annual survey. These physicians represent 45 diverse spe ...
9/21/2017
Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now. In a paper, ...
9/21/2017
Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego Sch ...
9/20/2017
Researchers at University of San Diego School of Medicine have developed a new tool called the San Diego Wisdom Scale (SD-WISE) to assess an individual’s level of wisdom, based upon a conceptualizatio ...



Follow Us